BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND TCF12, HEB, 6938, ENSG00000140262, HsT17266, HTF4
16 results:

  • 1. Revealing the pharmacological effects of Remodelin against osteosarcoma based on network pharmacology, acRIP-seq and experimental validation.
    Gao J; Xu P; Wang F; Zhang W; Min M; Urba R; Fan L
    Sci Rep; 2024 Feb; 14(1):3577. PubMed ID: 38347067
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of TAF15::NR4A3 Fusion.
    Huang SC; Lee JC; Hsu YC; Tsai JW; Kao YC; Hsieh TH; Chang YM; Chang KC; Wu PS; Chen PC; Chen CH; Chang CD; Lee PH; Tai HC; Liu TT; Wen MC; Li WS; Yu SC; Wang JC; Huang HY
    Mod Pathol; 2023 Jul; 36(7):100161. PubMed ID: 36948401
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions.
    Lenz J; Klubíčková N; Ptáková N; Hájková V; Grossmann P; Šteiner P; Kinkor Z; Švajdler M; Michal M; Konečná P; Macháčová D; Hurník P; Tichý M; Tichý F; Kyllar M; Fiala L; Kavka M; Michal M
    Hum Pathol; 2023 Apr; 134():19-29. PubMed ID: 36563884
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.
    Ngo C; Verret B; Vibert J; Cotteret S; Levy A; Pechoux CL; Haddag-Miliani L; Honore C; Faron M; Quinquis F; Cesne AL; Scoazec JY; Pierron G
    Genes Chromosomes Cancer; 2023 Jan; 62(1):52-56. PubMed ID: 35932215
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck.
    Agaimy A; Dermawan JK; Leong I; Stoehr R; Swanson D; Weinreb I; Zhang L; Antonescu CR; Dickson BC
    Genes Chromosomes Cancer; 2022 Dec; 61(12):701-709. PubMed ID: 35766997
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. SMARCA2-NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next-generation sequencing.
    Wei S; Pei J; von Mehren M; Abraham JA; Patchefsky AS; Cooper HS
    Genes Chromosomes Cancer; 2021 Oct; 60(10):709-712. PubMed ID: 34124809
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group.
    Paioli A; Stacchiotti S; Campanacci D; Palmerini E; Frezza AM; Longhi A; Radaelli S; Donati DM; Beltrami G; Bianchi G; Barisella M; Righi A; Benini S; Fiore M; Picci P; Gronchi A
    Ann Surg Oncol; 2021 Feb; 28(2):1142-1150. PubMed ID: 32572850
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma.
    Urbini M; Astolfi A; Pantaleo MA; Serravalle S; Dei Tos AP; Picci P; Indio V; Sbaraglia M; Benini S; Righi A; Gambarotti M; Gronchi A; Colombo C; Dagrada GP; Pilotti S; Maestro R; Polano M; Saponara M; Tarantino G; Pession A; Biasco G; Casali PG; Stacchiotti S
    Genes Chromosomes Cancer; 2017 Jul; 56(7):582-586. PubMed ID: 28383167
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
    Broehm CJ; Wu J; Gullapalli RR; Bocklage T
    Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.
    Agaram NP; Zhang L; Sung YS; Singer S; Antonescu CR
    Hum Pathol; 2014 May; 45(5):1084-91. PubMed ID: 24746215
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma.
    Benini S; Cocchi S; Gamberi G; Magagnoli G; Vogel D; Ghinelli C; Righi A; Picci P; Alberghini M; Gambarotti M
    J Mol Diagn; 2014 May; 16(3):314-23. PubMed ID: 24508382
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genetics of chondrosarcoma and related tumors.
    Sandberg AA
    Curr Opin Oncol; 2004 Jul; 16(4):342-54. PubMed ID: 15187889
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic organization of human tcf12 gene and spliced mRNA variants producing isoforms of transcription factor htf4.
    Gan TI; Rowen L; Nesbitt R; Roe BA; Wu H; Hu P; Yao Z; Kim UJ; O'Sickey T; Bina M
    Cytogenet Genome Res; 2002; 98(4):245-8. PubMed ID: 12826747
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses.
    Sjögren H; Meis-Kindblom JM; Orndal C; Bergh P; Ptaszynski K; Aman P; Kindblom LG; Stenman G
    Am J Pathol; 2003 Mar; 162(3):781-92. PubMed ID: 12598313
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Fusion of the NH2-terminal domain of the basic helix-loop-helix protein tcf12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21).
    Sjögren H; Wedell B; Meis-Kindblom JM; Kindblom LG; Stenman G
    Cancer Res; 2000 Dec; 60(24):6832-5. PubMed ID: 11156374
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.